コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ythemia vera, essential thrombocythemia, and idiopathic myelofibrosis.
2 haemia vera, essential thrombocythaemia, and idiopathic myelofibrosis.
3 lf those with essential thrombocythaemia and idiopathic myelofibrosis.
4 vera, essential thrombocytosis, and chronic idiopathic myelofibrosis.
5 thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.
6 thaemia vera, essential thrombocythaemia, or idiopathic myelofibrosis.
7 ycythemia vera and in 13 of 14 patients with idiopathic myelofibrosis.
8 orders such as essential thrombocythemia and idiopathic myelofibrosis.
9 I is characteristic of polycythemia vera and idiopathic myelofibrosis.
10 ith polycythemia vera and four patients with idiopathic myelofibrosis.
11 V617F mutants for polycythemia vera, chronic idiopathic myelofibrosis, and essential thrombocythemia
12 patients with essential thrombocythemia and idiopathic myelofibrosis, and less frequently in atypica
13 0 patients with polycythemia vera and 3 with idiopathic myelofibrosis, but not in 4 patients with ess
14 atients with polycythemia vera (PV), chronic idiopathic myelofibrosis (CIMF), and essential thrombocy
18 ents with essential thrombocythemia (ET) and idiopathic myelofibrosis (IMF) has greatly advanced our
20 ty-six patients, 10 to 66 years of age, with idiopathic myelofibrosis (IMF) or end-stage polycythemia
21 ve disorders (MPDs), polycythemia vera (PV), idiopathic myelofibrosis (IMF), and essential thrombocyt
22 egakaryocytic hyperplasia that characterizes idiopathic myelofibrosis (IMF), peripheral blood CD34+ c
23 nd a substantial proportion of patients with idiopathic myelofibrosis or essential thrombocythemia.
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。